MindWalk Holdings (HYFT) Payables (2020 - 2026)
MindWalk Holdings (HYFT) reported Payables of $2.4 million for Q1 2026, up 4020.0% year-over-year from $58310.1 in Q1 2025, and up 518.66% quarter-over-quarter from -$573819.7 in Q4 2025.
MindWalk Holdings (HYFT) Payables (2020 - 2026) Analysis & Trends
MindWalk Holdings (HYFT) has 7 years of Payables data on file, last reported at $2.4 million in Q1 2026.
- Payables for Q1 2026 came in at $2.4 million, up 4020.0% year-over-year; the trailing twelve-month figure through Jan 2026 was $2.4 million (up 4020.0% YoY), and the FY2025 annual result was $3.8 million, up 17.62% from the prior year.
- Payables rose to $2.4 million in Q1 2026 per HYFT's latest filing, from -$573819.7 in the prior quarter.
- Over five years, Payables peaked at $3.8 million in Q2 2022 and troughed at -$717596.3 in Q3 2025.
- A 5-year average of $1.3 million and a median of $1.1 million in 2024 frame the typical range for Payables.
- The sharpest annual moves came in 2025 and 2026: Payables plunged 176.9% in 2025, then surged 4020.0% in 2026.
- A 5-year view of Payables shows it stood at -$95617.7 in 2022, then jumped by 623.71% to $500758.3 in 2023, then soared by 49.01% to $746202.2 in 2024, then sank by 176.9% to -$573819.7 in 2025, then soared by 518.66% to $2.4 million in 2026.
- Business Quant data shows HYFT's Payables at $2.4 million in Q1 2026, -$573819.7 in Q4 2025, and -$717596.3 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | 1.05 Mn |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 300,549.00 |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 83.00 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | 8.69 Mn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 489.30 Mn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | 34.55 Mn |
| 10 | MindWalk Holdings | 166.20 Mn | 156.06 Mn | 1.78 | 2.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | 2.40 Mn |
| Oct 31, 2025 | -573,819.69 |
| Jul 31, 2025 | -717,596.34 |
| Apr 30, 2025 | 3.71 Mn |
| Jan 31, 2025 | -61,285.14 |
| Oct 31, 2024 | 746,202.19 |
| Jul 31, 2024 | 2.29 Mn |
| Apr 30, 2024 | 3.22 Mn |
| Jan 31, 2024 | 1.08 Mn |
| Oct 31, 2023 | 500,758.35 |
| Jul 31, 2023 | 181,307.32 |
| Apr 30, 2023 | 2.50 Mn |
| Jan 31, 2023 | -530,097.01 |
| Oct 31, 2022 | -95,617.72 |
| Jul 31, 2022 | 1.75 Mn |
| Apr 30, 2022 | 3.76 Mn |
| Jan 31, 2022 | 2.60 Mn |
| Oct 31, 2021 | 2.86 Mn |
| Jul 31, 2021 | 2.42 Mn |
| Apr 30, 2021 | 2.39 Mn |